We are live on ! Find out more
GHSI

Guardion Health Sciences, Inc. Common Stock
GHSI

Delisted

GHSI was delisted on the 11th of October, 2024.

Back to rankings

15 hedge funds and large institutions have $4.8M invested in Guardion Health Sciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

16% more capital invested

Capital invested by funds: $4.14M → $4.8M (+$661K)

7% more funds holding

Funds holding: 14 → 15 (+1)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$844K
2
Morgan Stanley
Morgan Stanley
New York
+$545K
3
State Street
State Street
Massachusetts
+$228K
4
Renaissance Technologies
Renaissance Technologies
New York
+$121K
5
VF
Virtu Financial
New York
+$54.6K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$96.1K
2
Citadel Advisors
Citadel Advisors
Florida
-$47.8K
3
UBS Group
UBS Group
Switzerland
-$2K
4
Bank of America
Bank of America
North Carolina
-$1.48K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.88M +$844K +9,717 +83%
BlackRock
2
BlackRock
New York
$1.01M -$96.1K -1,106 -9%
Renaissance Technologies
3
Renaissance Technologies
New York
$611K +$121K +1,396 +25%
Morgan Stanley
4
Morgan Stanley
New York
$575K +$545K +6,270 +2,322%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$298K +$47.6K +548 +19%
State Street
6
State Street
Massachusetts
$231K +$228K +2,622 New
VF
7
Virtu Financial
New York
$55K +$54.6K +628 New
SFI
8
Susquehanna Fundamental Investments
Pennsylvania
$49K +$48K +552 New
Citadel Advisors
9
Citadel Advisors
Florida
$44K -$47.8K -550 -52%
Northern Trust
10
Northern Trust
Illinois
$44K – – –
S
11
SignatureFD
Georgia
$2K – – –
Wells Fargo
12
Wells Fargo
California
$2K +$87 +1 +5%
FDCDDQ
13
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.47K – – –
Osaic Holdings
14
Osaic Holdings
Arizona
$1K – – –
Bank of America
15
Bank of America
North Carolina
– -$1.48K -17 Closed
UBS Group
16
UBS Group
Switzerland
– -$2K -16 Closed

GHSI Hedge Fund Activity: Q2 2021 in Review

15 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q2 2021, worth a combined $4.8M — up 16% from $4.14M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new GHSI positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $844K. The largest seller was BlackRock, cutting an estimated $96.1K.

  • 15 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q2 2021, up from 14 in Q1 2021.
  • Funds reported $4.8M of Guardion Health Sciences, Inc. Common Stock stock for Q2 2021, up 16% quarter-over-quarter.
  • 3 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q2 2021 and 2 closed out, a net change of +1 holder.
  • The largest Guardion Health Sciences, Inc. Common Stock buyer in Q2 2021 was Vanguard Group, an estimated $844K added.
  • The largest Guardion Health Sciences, Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $96.1K sold.

Based on aggregated 13F filings for Q2 2021.